Role of sirtuins in obesity and osteoporosis: molecular mechanisms and therapeutic targets
Authors:
Open Access
- 11 January 2025
- journal article
- review article
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 23 (1) , 1-37
Abstract
The prevalence of obesity and osteoporosis (OP) represents a significant public health concern on a global scale. A substantial body of evidence indicates that there is a complex relationship between obesity and OP, with a correlation between the occurrence of OP and obesity. In recent years, sirtuins have emerged as a prominent area of interest in the fields of aging and endocrine metabolism. Among the various research avenues exploring the potential of sirtuins, the effects of these proteins on obesity and OP have garnered significant attention from numerous researchers. Sirtuins regulate energy balance and lipid balance, which in turn inhibit the process of adipogenesis. Additionally, sirtuins regulate the balance between osteogenic and osteoblastic activity, which protects against the development of OP. However, no study has yet provided a comprehensive discussion of the relationship between the three: sirtuins, obesity, and OP. This paper will therefore describe the relationship between sirtuins and obesity, the relationship between sirtuins and OP, and a discussion focusing on the possibility of treating OP caused by obesity by targeting sirtuins. This will be based on the common influences on the occurrence of obesity and OP (such as mesenchymal stem cells, gut microbiota, and insulin). Finally, the potential of SIRT1, an important member of sirtuins, in polyphenolic natural products for the treatment of obesity and OP will be presented. This will contribute to a better understanding of the interactions between sirtuins and obesity and bone, which will facilitate the development of new therapeutic strategies for obesity and OP in the future.Keywords
Funding Information
- the Natural Science Foundation of Guangdong Province (Nos. 2021B1515140012, 2023A1515010083)
- the Dongguan Science and Technology of Social Development Program (No. 20211800905342)
- the Medical Scientific Research Foundation of Guangdong Province (No. A2024398)
- the Research and Development Fund of Dongguan People’ s Hospital (No. k202005)
- the Guangdong Medical University Students’ Innovation and Entrepreneurship Training Program (Nos. GDMU2021003, GDMU2021049, GDMU2022031, GDMU2022047, GDMU2022063, GDMU2022077, GDMU2022078, GDMU2023008, GDMU2023015, GDMU2023026, GDMU2023042, GDMU2023102)
- the Provincial and National College Students’ Innovation and Entrepreneurship Training Program (Nos. 202210571008, S202210571075, 202310571031, S202310571047, S202310571078, S202310571063, S202310571077)
- the Guangdong Medical University-Southern Medical University twinning research team project (No. 4SG24028G)
- "Climbing 100" Joint Merit Training Program Funded Project (No. PF100-2-01)
- the Cai Limin National Traditional Chinese Medicine Inheritance Studio
- the Guangdong Medical University Students’ Innovation Experiment Program (Nos. 2023ZYDS001, 2023FZDS001, 2023FYDB010)
This publication has 269 references indexed in Scilit:
- Leptin receptor 5′untranslated regions in the rat: relative abundance, genomic organization and relation to putative response elementsMolecular and Cellular Endocrinology, 2001
- Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid HomeostasisCell, 2000
- Genomic structure and mutations in adipose-specific gene, adiponectinInternational Journal of Obesity, 2000
- PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In VitroMolecular Cell, 1999
- Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in ObesityBiochemical and Biophysical Research Communications, 1999
- Cross-Regulation of C/EBPα and PPARγ Controls the Transcriptional Pathway of Adipogenesis and Insulin SensitivityMolecular Cell, 1999
- Hyperinsulinemia and bone mineral density in an elderly population: The Rotterdam studyBone, 1996
- Serum Immunoreactive-Leptin Concentrations in Normal-Weight and Obese HumansNew England Journal of Medicine, 1996
- Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factorCell, 1994
- Involvement of nitric oxide in noradrenaline-induced increase in blood flow through brown adipose tissueLife Sciences, 1994